F.L. Putnam Investment Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.2M | Buy |
317,563
+10,988
| +4% | +$768K | 0.38% | 54 |
|
|
2025
Q1 | $22.5M | Buy |
306,575
+13,001
| +4% | +$956K | 0.42% | 54 |
|
|
2024
Q4 | $19.2M | Buy |
293,574
+56,259
| +24% | +$3.69M | 0.35% | 60 |
|
|
2024
Q3 | $18.5M | Buy |
237,315
+2,455
| +1% | +$191K | 0.33% | 64 |
|
|
2024
Q2 | $18.3M | Sell |
234,860
-42,871
| -15% | -$3.34M | 0.34% | 64 |
|
|
2024
Q1 | $18.8M | Buy |
277,731
+5,637
| +2% | +$382K | 0.4% | 56 |
|
|
2023
Q4 | $18.3M | Buy |
272,094
+30,628
| +13% | +$2.06M | 0.43% | 53 |
|
|
2023
Q3 | $16.4M | Buy |
241,466
+3,112
| +1% | +$211K | 0.45% | 51 |
|
|
2023
Q2 | $17.1M | Buy |
238,354
+4,633
| +2% | +$332K | 0.46% | 46 |
|
|
2023
Q1 | $16.2M | Buy |
233,721
+9,136
| +4% | +$634K | 0.53% | 45 |
|
|
2022
Q4 | $15.2M | Buy |
224,585
+24,611
| +12% | +$1.67M | 0.55% | 47 |
|
|
2022
Q3 | $11M | Buy |
199,974
+4,896
| +3% | +$269K | 0.43% | 55 |
|
|
2022
Q2 | $12.9M | Buy |
195,078
+23,590
| +14% | +$1.56M | 0.47% | 52 |
|
|
2022
Q1 | $11.4M | Buy |
171,488
+4,513
| +3% | +$299K | 0.36% | 63 |
|
|
2021
Q4 | $9.73M | Buy |
166,975
+7,317
| +5% | +$426K | 0.3% | 69 |
|
|
2021
Q3 | $9.59M | Buy |
159,658
+59,777
| +60% | +$3.59M | 0.33% | 70 |
|
|
2021
Q2 | $5.98M | Buy |
99,881
+13,385
| +15% | +$802K | 0.21% | 96 |
|
|
2021
Q1 | $4.3M | Buy |
86,496
+8,386
| +11% | +$417K | 0.19% | 104 |
|
|
2020
Q4 | $3.91M | Buy |
+78,110
| New | +$3.91M | 0.18% | 100 |
|